| P&O Head Development & Biomedical Research Japan |
Head Office (Japan) (Pharmaceuticals) |
Japan |
People & Organization |
Innovative Medicines |
Humanressourcen |
Sep 03, 2024 |
| Manager - Field Effectiveness |
Hyderabad (Office) |
Indien |
Operations |
CTS |
Marketing |
Sep 03, 2024 |
| Associate Director, Veeva CRM Architect |
Barcelona Gran Vía |
Spanien |
Operations |
CTS |
Technology Transformation |
Sep 03, 2024 |
| Principal Scientist, Modeling & Simulation RLT |
Cambridge (USA) |
USA |
Biomedical Research |
Pharma Research |
Research & Development |
Sep 03, 2024 |
| QA Specialist APQR |
INSURGENTES |
Mexiko |
Operations |
Innovative Medicines |
Quality |
Sep 03, 2024 |
| RA Manager |
INSURGENTES |
Mexiko |
Development |
Innovative Medicines |
Research & Development |
Sep 03, 2024 |
| Clinical Biospecimen Senior Scientist |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Development |
Innovative Medicines |
Research & Development |
Sep 03, 2024 |
| QC Analyst |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Quality |
Sep 03, 2024 |
| Solution Design |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Marketing |
Sep 03, 2024 |
| Market Access Specialist |
Hefei (Anhui Province) |
China |
International |
Innovative Medicines |
Market Access |
Sep 03, 2024 |
| Expert Science & Technology |
Changshu (Jiangsu Province) |
China |
Development |
Innovative Medicines |
Research & Development |
Sep 03, 2024 |
| Office Manager – Public Affairs (f/m/d) |
Berlin West (Non-Sales Force) (Novartis Pharma GmbH) |
Deutschland |
Corporate Affairs |
Innovative Medicines |
Einrichtungen und Verwaltung |
Sep 02, 2024 |
| Intake Specialist |
INSURGENTES |
Mexiko |
US |
Innovative Medicines |
Einrichtungen und Verwaltung |
Sep 02, 2024 |
| Director, Non-Clinical Statistics |
Cambridge (USA) |
USA |
Biomedical Research |
Pharma Research |
Research & Development |
Sep 02, 2024 |
| Renal Medical Lead |
Seoul |
Südkorea |
International |
Innovative Medicines |
Research & Development |
Sep 01, 2024 |
| Regulatory Affairs Manager |
Beijing (Beijing) |
China |
Development |
Innovative Medicines |
Research & Development |
Sep 01, 2024 |
| (高级）医药代表 /（资深）产品专员 |
Xianyang (Shanxi Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
Aug. 30, 2024 |
| REFS Key Account & Business Relationship Manager |
Basel (City) |
Schweiz |
Operations |
CTS |
Einrichtungen und Verwaltung |
Aug. 30, 2024 |
| (高级）医药代表 /（资深）产品专员 |
Xianyang (Shanxi Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
Aug. 30, 2024 |
| Senior Clinical Development Medical Director - Renal |
East Hanover |
USA |
Development |
Innovative Medicines |
Research & Development |
Aug. 30, 2024 |
| (高级）医药代表 /（资深）产品专员 |
Xianyang (Shanxi Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
Aug. 30, 2024 |
| TCM Senior Cash Management Specialist |
INSURGENTES |
Mexiko |
Operations |
CTS |
Audit und Finanzen |
Aug. 30, 2024 |
| (高级）医药代表 /（资深）产品专员 |
Xianyang (Shanxi Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
Aug. 30, 2024 |
| (高级）医药代表 /（资深）产品专员 |
Xianyang (Shanxi Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
Aug. 30, 2024 |
| (高级）医药代表 /（资深）产品专员 |
Xianyang (Shanxi Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
Aug. 30, 2024 |
| (高级）医药代表 /（资深）产品专员 |
Xianyang (Shanxi Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
Aug. 30, 2024 |
| (高级）医药代表 /（资深）产品专员 |
Xianyang (Shanxi Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
Aug. 30, 2024 |
| (高级）医药代表 /（资深）产品专员 |
Xianyang (Shanxi Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
Aug. 30, 2024 |
| (高级）医药代表 /（资深）产品专员 |
Xianyang (Shanxi Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
Aug. 30, 2024 |
| (高级）医药代表 /（资深）产品专员 |
Xianyang (Shanxi Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
Aug. 30, 2024 |
| Group Head, Global Aggregate Reports & Risk Management |
Barcelona Gran Vía |
Spanien |
Development |
Innovative Medicines |
Research & Development |
Aug. 29, 2024 |
| Customer Engagement &Solution Partner |
Lithuania |
Litauen |
International |
Innovative Medicines |
Der Umsatz |
Aug. 29, 2024 |
| Schichtleiter II / Abteilungsleiter |
Schaftenau |
Österreich |
Operations |
Innovative Medicines |
Technical Operations |
Aug. 28, 2024 |
| Snr. Specialist MDM (Master Data Management - implementation using Reltio) |
Hyderabad (Office) |
Indien |
Operations |
CTS |
Technology Transformation |
Aug. 28, 2024 |
| Snr Specialist(Power BI & Embedded Analytics - Web applications) |
Hyderabad (Office) |
Indien |
Operations |
CTS |
Technology Transformation |
Aug. 28, 2024 |
| Director, Non-Clinical Statistics |
Basel (City) |
Schweiz |
Biomedical Research |
Pharma Research |
Research & Development |
Aug. 28, 2024 |
| (高级）地区经理 |
Taiyuan (Shanxi Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
Aug. 28, 2024 |
| Tehnolog proizv. inženiringa lokacije za področje avtomatizacije (m/ž/d) / Engineer Multidiscipline - automation area (m/f/d) |
Mengeš |
Slowenien |
Operations |
Innovative Medicines |
Technical Operations |
Aug. 27, 2024 |
| Sr. Spec. DDIT IES Database Services |
INSURGENTES |
Mexiko |
Operations |
CTS |
Technology Transformation |
Aug. 27, 2024 |
| Patient Safety Specialist |
Amiria |
Ägypten |
Development |
Innovative Medicines |
Research & Development |
Aug. 26, 2024 |
| Buyer with German |
Prague |
Tschechische Republik |
Operations |
CTS |
Beschaffung |
Aug. 23, 2024 |
| (高级）医药代表 /（资深）产品专员 |
Nanyang (Henan Province) |
China |
International |
Innovative Medicines |
Der Umsatz |
Aug. 23, 2024 |
| FRA Technical Accounting & Special Projects APMA |
Selangor |
Malaysia |
Operations |
CTS |
Audit und Finanzen |
Aug. 22, 2024 |
| Ethics, Risk & Compliance Manager |
Selangor |
Malaysia |
Ethics Risk & Compliance |
Innovative Medicines |
Legal & Intellectual Property & Compliance |
Aug. 22, 2024 |
| Director Biostatistics |
London (The Westworks) |
Vereinigtes Königreich |
Development |
Innovative Medicines |
Research & Development |
Aug. 22, 2024 |
| Associate Director, Business Analyst, DDIT Dev., Technical Research & Development (TRD) |
Barcelona Gran Vía |
Spanien |
Operations |
CTS |
Technology Transformation |
Aug. 22, 2024 |
| Business Planning and Analysis Manager, Novartis Technical Operations |
INSURGENTES |
Mexiko |
Finance |
Innovative Medicines |
Audit und Finanzen |
Aug. 22, 2024 |
| Senior China Program Head |
Beijing (Beijing) |
China |
Development |
Innovative Medicines |
Research & Development |
Aug. 22, 2024 |
| Sr Specialist DDIT IM JP & APMA Soln Int |
Selangor |
Malaysia |
Operations |
CTS |
Technology Transformation |
Aug. 22, 2024 |
| Associate Clinical Development Medical Director |
Shanghai (Shanghai) |
China |
Development |
Innovative Medicines |
Research & Development |
Aug. 22, 2024 |